Related Experiment Video
Updated: Apr 27, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanisms
Eleftherios Michailidis1, Andrew D Huber2, Emily M Ryan1
1From the Christopher Bond Life Sciences Center and Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, Missouri 65211.
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is a potent HIV-1 inhibitor that works through multiple mechanisms, including chain termination and misincorporation. Its unique action makes HIV resistance to EFdA difficult to develop.
Area of Science:
- Virology
- Medicinal Chemistry
- Molecular Biology
Background:
- 4 '-Ethynyl-2-fluoro-2 '-deoxyadenosine (EFdA) is a novel nucleoside analog with potent anti-human immunodeficiency virus type 1 (HIV-1) activity.
- Unlike approved nucleoside reverse transcriptase inhibitors (NRTIs), EFdA possesses a 3 '-OH group, contributing to its unique inhibitory profile.
Purpose of the Study:
- To elucidate the multifaceted mechanisms by which EFdA triphosphate (EFdA-TP) inhibits HIV-1 reverse transcriptase (RT).
- To understand how EFdA's unique properties contribute to its efficacy against wild-type and drug-resistant HIV-1 strains.
Main Methods:
- Investigated the interaction of EFdA-TP with HIV-1 RT using biochemical assays.
- Analyzed the impact of template sequence context on EFdA incorporation and subsequent DNA synthesis inhibition.
- Evaluated the potential for resistance development to EFdA.
Main Results:
- EFdA-TP inhibits HIV-1 RT via multiple mechanisms: translocation-defective (immediate) chain termination, delayed chain termination, and misincorporation leading to mismatched primers.
- EFdA-MP-terminated primers exhibit resistance to excision, enhancing inhibitory effects.
- The template sequence influences the predominant inhibition mechanism and EFdA-MP affinity, explaining lack of antagonism with tenofovir.
Conclusions:
- EFdA exhibits versatile inhibition of HIV-1 replication through distinct molecular mechanisms.
- The multi-pronged inhibitory action of EFdA contributes to the difficulty in developing resistance, offering a promising avenue for HIV-1 therapy.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Viruses with RNA Genomes
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Inhibitors of Bacterial DNA Synthesis